As the private sector contributes to advancing equity, corporate leaders are looking for ways to create positive impact through new practices, policies, and, importantly—their core business. They consider how their purpose, culture, and governance align with their equity ambitions and the leadership it takes to bring commitments to fruition.
Hear from a Global Fortune 500 CEO who is reimagining the ways his company uses innovative science, technology, and an “inspired, curious, unbossed” culture to deliver greater access to medicines.
- Sebastien Mazzuri (event host) – Managing Director, FSG
- Vas Narasimhan – CEO, Novartis
- Alyson Shontell – Editor-in-Chief, Fortune